Paraoxonase 1 (PON1) is present in postprandial chylomicrons

被引:47
作者
Fuhrman, B
Volkova, N
Aviram, M [1 ]
机构
[1] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Fac Med, Lipid Res Lab, IL-31096 Haifa, Israel
[2] Rambam Med Ctr, IL-31096 Haifa, Israel
关键词
paraoxonases 1 (PON1); chylomicrons; VLDL; LDL; HDL; lipid peroxides; postprandial state;
D O I
10.1016/j.atherosclerosis.2004.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Paraoxonase 1 (PON1) is an esterase, associated in serum with high density lipoprotein (HDL). As diet affects serum PON1 activity, we questioned whether PON1 is also carried by postprandial chylomicrons. Chylomicrons were isolated by ultracentrifugation from plasma of 10 healthy men, 3 h after the consumption of a high fat, high carbohydrate meal, and were analyzed for the presence of PON1 arylesterase activity and protein. The present study shows for the first time that, in addition to the presence of PON1 mainly on HDL, postprandial chylomicrons also contain minor, but significant amount of PON1. PON1 was also present in chylomicrons derived from fasted patients with hyperchylomicronemia. In addition, PON1 was detected in very low density lipoprotein (VLDL), but not in LDL. The origin of chylomicron PON1 could be partly attributed to its transfer from HDL. Finally, this study demonstrates that postprandial chylomicrons inhibit copper ion-induced LDL oxidation, secondary to hydrolysis of lipid peroxides, a phenomenon which could be related, at least in part, to the chylomicron PON1 content. We conclude that postprandial chylomicrons contain PON1, which may function in the removal of atherogenic oxidized lipids. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 30 条
[1]   PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[2]   Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].
Aviram, M ;
Hardak, E ;
Vaya, J ;
Mahmood, S ;
Milo, S ;
Hoffman, A ;
Billicke, S ;
Draganov, D ;
Rosenblat, M .
CIRCULATION, 2000, 101 (21) :2510-2517
[3]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[4]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[5]  
Aviram M, 2001, METHOD ENZYMOL, V335, P244
[6]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062
[7]   Beyond cholesterol: the enigma of atherosclerosis revisited [J].
Bhakdi, S ;
Lackner, KJ ;
Han, SR ;
Torzewski, M ;
Husmann, M .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (04) :639-645
[8]   Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activity [J].
Connelly, PW ;
Maguire, GF ;
Draganov, DI .
JOURNAL OF LIPID RESEARCH, 2004, 45 (03) :561-566
[9]   Acetylcholine esterase protects LDL against oxidation [J].
Fuhrman, B ;
Partoush, A ;
Aviram, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 322 (03) :974-978
[10]  
GAN KN, 1991, DRUG METAB DISPOS, V19, P100